Score Overview
See the full market ranking โ
Arcadia Biosciences Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 8M to $ 4M and net income went from -$ 4M to -$ 2M. Revenue increased in 2 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 5M to $ 4M and net income went from -$ 17M to -$ 2M. Revenue increased in 4 of those 10 years; net income in 6.
Arcadia Biosciences Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.70 | โ |
1 Year2025-08-12 | $ 4.45 | -84.27% |
5 Years2021-08-12 | $ 95.20 | -99.26% |
10 Years2016-08-12 | $ 1.62K | -99.96% |
All Time2015-05-15 | $ 5.84K | -99.99% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-05-15 |
|---|---|---|---|---|---|
| Price | $ 0.70 | $ 4.45 | $ 95.20 | $ 1.62K | $ 5.84K |
| Return | โ | -84.27% | -99.26% | -99.96% | -99.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 4M | -$ 2M | $ 4M |
| 2024 | $ 5M | -$ 7M | $ 4M |
| 2023 | $ 4M | -$ 13M | $ 11M |
| 2022 | $ 7M | -$ 15M | $ 20M |
| 2021 | $ 6M | -$ 14M | $ 28M |
| 2020 | $ 8M | -$ 4M | $ 25M |
| 2019 | $ 1M | -$ 28M | $ 25M |
| 2018 | $ 1M | -$ 13M | $ 21M |
| 2017 | $ 4M | -$ 15M | $ 13M |
| 2016 | $ 3M | -$ 19M | $ 50M |
| IPO2015 | $ 5M | -$ 17M | $ 50M |
Explore beyond RKDA
You're looking at Arcadia Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
